In a 71-week, double-blind study, Nova Nordisk—creators of the popular weight loss drug Wegovy—says their oral semaglutide ...

Novo Nordisk has cut prices of its weight-loss drug Wegovy by up to 37% in India. This move intensifies competition with Eli ...

The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.

Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.

The starting dose of 0.25 mg will now cost Rs 2,712 per week, down from Rs 4,336 earlier, with the new prices effective ...

Drugmaker Eli Lilly said it would soon start late-stage trials for eloralintide, a drug mimicking the pancreatic hormone ...

US President Donald Trump has announced deals that aim to lower the cost of popular weight-loss drugs, as pharmaceutical ...

President Donald Trump announced that his administration has finally struck a deal with Novo Nordisk and Eli Lilly to reduce ...

Wegovy, Mounjaro, Semaglutide, Tirzepatide, Novo Nordisk, Eli Lilly, Emcure, Cipla, Obesity, Obesity in India, Weight loss drug, weight management ...

Access to the drugs has been a consistent problem for patients because of their cost — around $500 a month for higher doses — ...

The deal is expected to lower the price of some obesity drugs to $149 per month in certain cases, according to reports.

Our Bureau, Mumbai Monday, November 10, 2025, 12:45 Hrs [IST] ...